The demonstration by Francis and Tillett (1) and others (2-5) that the typespecific polysaccharides of pneumococci are antigenic in man and induce the production of antibodies in humans which protect mice against subsequent injection of virulent organisms, has led to numerous attempts to use these purified polysaccharides in active immunization (4, 6). Since the antipolysaccharide in Type I antimeningococcal sera has also been found to be effective in protecting mice, the capacity of several preparations of Type I meningococcal polysaccharide to induce precipitin formation in human volunteers was studied. Use was made of the colorimetric micro method for the estimation of antibody developed by Heidelberger and MacPherson (7) and applied in a study of the antibody response accompanying convalescence from pneumonia (8).Preparations of the specific polysaccharide of the Type I meningococcus have been made and characterized by Scherp and Rake (9). Their materials, however, were shown to contain at least 20 per cent of a second substance which reacted with antimeningococcal sera (10) but was found not to remove protective antibody (11). A sample of polysaccharide (preparation 18 (9)) was generously supplied by Dr. H. W. Scherp for use in this investigation. In addition, since both glacial acetic acid and barium hydroxide had been used in purifying their polysaccharide, several lots were prepared in which the use of these fairly drastic reagents was avoided. The chemical and immunological properties of these materials were studied and it was found that, unlike preparation 18, they showed only a slight zone in the quantitative precipitin reaction where both antigen and antibody could be detected in the supernatant. No evidence 6f precipitin formation in humans was obtained with preparation 18, but in a few instances a small but significant antibody response to injection of *